SB 211-FN (2006): relative to pharmaceutical marketers.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“SB 211-FN (2006): relative to pharmaceutical marketers.” Granite Record, https://graniterecord.org/bill/2006/sb211. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). SB 211-FN (2006): relative to pharmaceutical marketers. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2006/sb211
Chicago
Granite Record. “SB 211-FN (2006): relative to pharmaceutical marketers.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2006/sb211.
BibTeX
@misc{bill-2006-sb211, title = {SB 211-FN (2006): relative to pharmaceutical marketers.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2006/sb211}, note = {Accessed 24 Oct. 2026} }

SB 211-FN (2006)

relative to pharmaceutical marketers.

  • Status: Referred for interim study
  • Term: 2005-2006
  • House committee: Commerce
  • Senate committee: Executive Departments and Administration
  • Subject: Miscellaneous

The Story

It was introduced on January 6, 2005 and referred to the Senate Executive Departments and Administration committee. The committee held a public hearing on February 9, 2005. The committee recommended that the Senate pass it. On March 10, 2005 the Senate voted to pass it on a voice vote and ordered it to a third reading. On March 10, 2005 the Senate voted to pass it. It crossed to the House and was referred to the House Commerce committee. The committee held a public hearing on April 12, 2005. The committee held a work session on April 28, 2005. The committee retained the bill, holding it for further work rather than reporting it out this year. The committee held a work session on September 21, 2005. The committee voted unanimously, 19–0, to recommend that the House study it after the session ends, and the report was placed on the consent calendar. The bill was taken off the consent calendar on January 4, 2006. On January 4, 2006 the House adopted “Special Order to regular place on Reg Cal for Jan 18 Without Objection”. On January 18, 2006 the House voted to study it after the session ends on a voice vote. The committee held a work session on September 27, 2006. The committee reported back on its interim study of the bill: “NOT REC FOR LEGIS”, by a vote of 14 to 3.

Sponsors

Hearings and Sessions

  • February 9, 2005, 1:50 PM: hearing, Senate Executive Departments and Administration, LOB 102
  • April 12, 2005, 11:00 AM: hearing, RM303,LOB (NOTE ROOM CHANGE)
  • April 28, 2005, 10:00 AM: subcommittee work session, RM302,LOB <Rep J Martin>
  • September 21, 2005, 10:00 AM: subcommittee work session, RM302,LOB <Rep J Martin>
  • September 27, 2006, 10:30 AM: subcommittee work session, LOB 302

Votes

  • March 10, 2005, Senate: Ought to Pass — voice vote, passed
  • January 18, 2006, House: Refer for Interim Study — voice vote, passed

The Docket

  • January 6, 2005: Introduced and Referred to Executive Departments and Administration
  • February 9, 2005: Hearing; February 9, 2005, Room 102, LOB, 1:50 p.m.; SC6
  • February 25, 2005: Committee Report; Ought to Pass, [03/10/05]; SC9
  • March 9, 2005: 03/09/2005 Introduced and ref to Commerce
  • March 10, 2005: Ought to Pass, MA, VV; OT3rdg
  • March 10, 2005: Passed by Third Reading Resolution
  • April 12, 2005: Hearing Apr 12 11:00 RM303,LOB (NOTE ROOM CHANGE)
  • April 28, 2005: Subcommittee Work Session Apr 28 10:00 RM302,LOB <Rep J Martin>
  • May 24, 2005: Retained in committee
  • September 21, 2005: Ret Subcommittee Work Session Sep 21 10:00 RM302,LOB <Rep J Martin>
  • November 30, 2005: Comm Report for Jan 4, 2006; Refer Interim Study (vote 19-0;CC)
  • January 4, 2006: Removed from Consent Cal req Rep DeJoie
  • January 4, 2006: Special Order to regular place on Reg Cal for Jan 18 Without Objection
  • January 18, 2006: Refer for Interim Study, MA, VV
  • May 24, 2006: ref to Commerce for Interim Study
  • June 29, 2006: Interim Study Subcommittee Members: Reps. Martin, Headd, McLeod
  • September 27, 2006: Interim Study Subcom Work Session Sept 27 10:30 LOB 302
  • October 18, 2006: Interim Study Report: NOT REC FOR LEGIS (Vote 14-3)

Related Bills

  • SB 61 (2007): relative to pharmaceutical marketers.
  • HB 703-FN (2006): relative to advertisement of prescription drugs and establishing the pharmaceutical marketing disclosure law.

From the General Court